These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20024046)

  • 1. Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.
    Gleghorn JP; Pratt ED; Denning D; Liu H; Bander NH; Tagawa ST; Nanus DM; Giannakakou PA; Kirby BJ
    Lab Chip; 2010 Jan; 10(1):27-9. PubMed ID: 20024046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device.
    Dharmasiri U; Balamurugan S; Adams AA; Okagbare PI; Obubuafo A; Soper SA
    Electrophoresis; 2009 Sep; 30(18):3289-300. PubMed ID: 19722212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device.
    Kirby BJ; Jodari M; Loftus MS; Gakhar G; Pratt ED; Chanel-Vos C; Gleghorn JP; Santana SM; Liu H; Smith JP; Navarro VN; Tagawa ST; Bander NH; Nanus DM; Giannakakou P
    PLoS One; 2012; 7(4):e35976. PubMed ID: 22558290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a hybrid dielectrophoresis and immunocapture microfluidic system for cancer cell capture.
    Huang C; Santana SM; Liu H; Bander NH; Hawkins BG; Kirby BJ
    Electrophoresis; 2013 Nov; 34(20-21):2970-9. PubMed ID: 23925921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices.
    Santana SM; Liu H; Bander NH; Gleghorn JP; Kirby BJ
    Biomed Microdevices; 2012 Apr; 14(2):401-7. PubMed ID: 22143878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment of prostate cancer cells from blood cells with a hybrid dielectrophoresis and immunocapture microfluidic system.
    Huang C; Liu H; Bander NH; Kirby BJ
    Biomed Microdevices; 2013 Dec; 15(6):941-8. PubMed ID: 23807279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERS-Based Pump-Free Microfluidic Chip for Highly Sensitive Immunoassay of Prostate-Specific Antigen Biomarkers.
    Gao R; Lv Z; Mao Y; Yu L; Bi X; Xu S; Cui J; Wu Y
    ACS Sens; 2019 Apr; 4(4):938-943. PubMed ID: 30864786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parametric control of collision rates and capture rates in geometrically enhanced differential immunocapture (GEDI) microfluidic devices for rare cell capture.
    Smith JP; Lannin TB; Syed Y; Santana SM; Kirby BJ
    Biomed Microdevices; 2014 Feb; 16(1):143-51. PubMed ID: 24078270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific antibody modification and immobilization on a microfluidic chip to promote the capture of circulating tumor cells and microemboli.
    Lai CH; Choon Lim S; Wu LC; Wang CF; Tsai WS; Wu HC; Chang YC
    Chem Commun (Camb); 2017 Apr; 53(29):4152-4155. PubMed ID: 28352905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunofunctional photodegradable poly(ethylene glycol) hydrogel surfaces for the capture and release of rare cells.
    LeValley PJ; Tibbitt MW; Noren B; Kharkar P; Kloxin AM; Anseth KS; Toner M; Oakey J
    Colloids Surf B Biointerfaces; 2019 Feb; 174():483-492. PubMed ID: 30497010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection.
    Sabile A; Louha M; Bonte E; Poussin K; Vona G; Mejean A; Chretien Y; Bougas L; Lacour B; Capron F; Roseto A; Bréchot C; Paterlini-Bréchot P
    Am J Clin Pathol; 1999 Aug; 112(2):171-8. PubMed ID: 10439796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis.
    Thege FI; Lannin TB; Saha TN; Tsai S; Kochman ML; Hollingsworth MA; Rhim AD; Kirby BJ
    Lab Chip; 2014 May; 14(10):1775-84. PubMed ID: 24681997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of protein expression on cancer cell capture using the Human Transferrin Receptor (CD71) as an affinity ligand.
    Lyons VJ; Helms A; Pappas D
    Anal Chim Acta; 2019 Oct; 1076():154-161. PubMed ID: 31203960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-free impedance detection of cancer cells from whole blood on an integrated centrifugal microfluidic platform.
    Nwankire CE; Venkatanarayanan A; Glennon T; Keyes TE; Forster RJ; Ducrée J
    Biosens Bioelectron; 2015 Jun; 68():382-389. PubMed ID: 25613813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detection.
    Autebert J; Coudert B; Champ J; Saias L; Guneri ET; Lebofsky R; Bidard FC; Pierga JY; Farace F; Descroix S; Malaquin L; Viovy JL
    Lab Chip; 2015 May; 15(9):2090-101. PubMed ID: 25815443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer.
    Abdolahi M; Shahbazi-Gahrouei D; Laurent S; Sermeus C; Firozian F; Allen BJ; Boutry S; Muller RN
    Contrast Media Mol Imaging; 2013; 8(2):175-84. PubMed ID: 23281290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell copy number analysis of prostate cancer cells captured with geometrically enhanced differential immunocapture microdevices.
    Pratt ED; Stepansky A; Hicks J; Kirby BJ
    Anal Chem; 2014 Nov; 86(22):11013-7. PubMed ID: 25363873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunoassay for the measurement of complexed prostate-specific antigen in serum.
    Allard WJ; Zhou Z; Yeung KK
    Clin Chem; 1998 Jun; 44(6 Pt 1):1216-23. PubMed ID: 9625045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis.
    Cho H; Chung JI; Kim J; Seo WI; Lee CH; Morgan TM; Byun SS; Chung JS; Han KH
    Cancer Sci; 2021 Feb; 112(2):859-870. PubMed ID: 33232539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.
    Elsässer-Beile U; Wolf P; Gierschner D; Bühler P; Schultze-Seemann W; Wetterauer U
    Prostate; 2006 Sep; 66(13):1359-70. PubMed ID: 16894535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.